Turku Bioscience – Turku Centre for Biotechnology

Recent publications

Kurppa et. al. Good Guy in Bad Company: How STRNs Convert PP2A into an Oncoprotein. Cancer Cell. 2020 Jul 13;38(1):20-22. Pubmed→

Jokela et. al. Fetal -Derived Macrophages Persist and Sequentially Maturate in Ovaries After Birth in Mice. European Journal of Immunology. May 27, 2020. Pubmed→

Wang et. al. Mesoporous carbon microfibers for electroactive materials derived from lignocellulose nanofibrils. American Chemical Society. May 13, 202. Link to text→

Westermarck et. al. Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer Therapy. Cell. Volume 181, ISSUE 3, P514-517, April 30, 2020. Link to text→

Rytkönen KT. et al. Transcriptomic responses to hypoxia in endometrial and decidual stromal cells. Reproduction. 2020 Apr 1. Pubmed→

Platis M. et al. The Interaction of Schistosoma Japonicum Glutathione Transferase With Cibacron Blue 3GA and Its Fragment. Journal of Medicinal Chemistry. 2020 Apr 2[Online ahead of print]. Pubmed→

Lerche M. et al. Integrin Binding Dynamics Modulate Ligand-Specific Mechanosensing in Mammary Gland Fibroblasts. iScience. 2020 Feb 13;23(3). Pubmed→

Stubb A. et al. Fluctuation-Based Super-Resolution Traction Force Microscopy. Nano Lett. 2020 Mar 20. Pubmed→

Mohd MK. et al. CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling. iScience. Volume 23, ISSUE 3, 100947, March 27, 2020. Link to Text→

Georgakis N. et al. Comparative structural and functional analysis of phi class glutathione transferases involved in multiple-herbicide resistance of grass weeds and crops. Plant Physiol Biochem. 2020 Feb 20;149:266-276. Pubmed→

Hui W. et al. Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer’s Disease Pathogenesis in Cell and Animal Models. Neurotherapeutics. 24/02/2020. Link to text→

Kauko O. et al. Phosphoproteome and drug response effects mediated by the three Protein Phosphatase 2A inhibitor proteins CIP2A, SET and PME-1. J Biol Chem. 2020 Feb 18. Pubmed→

Merisaari J. et al. Monotherapy efficacy of blood–brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma. Brain Communications, Volume 2, Issue 1, 2020. Link to text→

Miner MW. et al. (2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models. Mol Imaging Biol. 2020 Jan 28. Pubmed→

Qiao X. et al. UBR5 is co-amplified with MYC in breast tumors and encodes an ubiquitin ligase that limits MYC-dependent apoptosis. Cancer Res. 2020 Feb 6. Pubmed→

Andersen L. et al. The Transcription Factor MAZR/PATZ1 Regulates the Development of FOXP3+ Regulatory T Cells. Cell Rep. 29:4447-4459.e6, 2019. Pubmed→

Joutsen J. et al. Heat Shock Factor 2 Protects against Proteotoxicity by Maintaining Cell-Cell Adhesion. Cell Rep. 2020 Jan 14;30(2):583-597.e6. Pubmed→

Mohsin I. et al. Crystal Structure of a GH3 β-Glucosidase from the Thermophilic Fungus Chaetomium thermophilum. Int J Mol Sci. 2019 Nov 27;20(23). Pubmed→

Mäkelä E et al. Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia. Cancers (Basel). 2019 Nov 11;11(11). Pubmed→

Wang L et al. Effects of non-solvents and electrolytes on the formation and properties of cellulose I filaments. Sci Rep. 2019 Nov 13;9(1):16691 Pubmed→

Konki M. et al. Peripheral blood DNA methylation differences in twin pairs discordant for Alzheimer's disease. Clinical Epigenetics. 2019 Sep 2;11(1):130. Pubmed→

Papageorgiou AC. X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes. Adv Exp Med Biol. 2019;1148:81-103. Pubmed→

Shentu AP et al. Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Over- production Through Inhibiting CIP2A.Curr Alzheimer Res. 2019 Aug 30. Pubmed→

Home